Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Assets Average (2019 - 2025)

Silo Pharma (SILO) has disclosed Assets Average for 7 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 12.45% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, down 12.45% year-over-year, with the annual reading at $7.5 million for FY2025, 0.93% down from the prior year.
  • Assets Average hit $7.0 million in Q4 2025 for Silo Pharma, up from $6.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $12.3 million in Q4 2022 to a low of $3.5 million in Q1 2021.
  • Historically, Assets Average has averaged $8.4 million across 5 years, with a median of $8.2 million in 2021.
  • Biggest five-year swings in Assets Average: surged 671.77% in 2021 and later plummeted 35.2% in 2024.
  • Year by year, Assets Average stood at $10.9 million in 2021, then grew by 12.85% to $12.3 million in 2022, then tumbled by 32.23% to $8.4 million in 2023, then fell by 4.51% to $8.0 million in 2024, then dropped by 12.45% to $7.0 million in 2025.
  • Business Quant data shows Assets Average for SILO at $7.0 million in Q4 2025, $6.5 million in Q3 2025, and $6.3 million in Q2 2025.